D. Bucher

464 total citations
18 papers, 376 citations indexed

About

D. Bucher is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, D. Bucher has authored 18 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Neurology. Recurrent topics in D. Bucher's work include Diabetes Management and Research (4 papers), Porphyrin Metabolism and Disorders (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). D. Bucher is often cited by papers focused on Diabetes Management and Research (4 papers), Porphyrin Metabolism and Disorders (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). D. Bucher collaborates with scholars based in Denmark and Sweden. D. Bucher's co-authors include Johannes Thomsen, Niels‐Henrik Holstein‐Rathlou, Gedske Daugaard, Ivan Bruunshuus, Paul P. Leyssac, Ulrik Abildgaard, Ebba Nexø, Johan Stenflo, Henrik Olesen and Hendrik Vilstrup and has published in prestigious journals such as FEBS Letters, European Journal of Biochemistry and Clinical Pharmacology & Therapeutics.

In The Last Decade

D. Bucher

18 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Bucher Denmark	10	123	81	59	44	40	18	376
Michael J. Haut United States	10	71 0.6×	91 1.1×	30 0.5×	21 0.5×	119 3.0×	20	472
B. Morsches Germany	11	125 1.0×	51 0.6×	76 1.3×	12 0.3×	21 0.5×	101	574
N E Huseby Norway	11	93 0.8×	93 1.1×	70 1.2×	9 0.2×	109 2.7×	18	449
Noriyuki Sunahara Japan	12	147 1.2×	18 0.2×	52 0.9×	17 0.4×	31 0.8×	28	507
Russell R. Moores United States	14	105 0.9×	28 0.3×	40 0.7×	180 4.1×	85 2.1×	38	538
Masafumi Fukushima Japan	13	104 0.8×	224 2.8×	57 1.0×	12 0.3×	54 1.4×	23	508
John Date Denmark	18	107 0.9×	63 0.8×	424 7.2×	73 1.7×	45 1.1×	39	730
G. Brante Sweden	11	131 1.1×	37 0.5×	37 0.6×	54 1.2×	58 1.4×	27	544
Motoshi Kitamura Japan	11	203 1.7×	17 0.2×	139 2.4×	20 0.5×	28 0.7×	25	374
Henry M. Middleton United States	9	66 0.5×	39 0.5×	25 0.4×	22 0.5×	9 0.2×	15	344

Countries citing papers authored by D. Bucher

Since Specialization

Citations

This map shows the geographic impact of D. Bucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bucher more than expected).

Fields of papers citing papers by D. Bucher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bucher. The network helps show where D. Bucher may publish in the future.

Co-authorship network of co-authors of D. Bucher

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bucher. A scholar is included among the top collaborators of D. Bucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bucher. D. Bucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Sparre, Thomas, et al.. (2013). Injection force and dose accuracy of FlexTouch for the delivery of a new basal insulin. Expert Opinion on Drug Delivery. 10(12). 1613–1619. 8 indexed citations

2.

Bucher, D., et al.. (2011). A Prefilled Insulin Pen with a Novel Injection Mechanism and a Lower Injection Force than Other Prefilled Insulin Pens. Diabetes Technology & Therapeutics. 13(12). 1207–1211. 20 indexed citations

3.

Bucher, D., et al.. (2011). An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen. Expert Opinion on Drug Delivery. 8(10). 1271–1276. 12 indexed citations

4.

Bucher, D., et al.. (2011). FlexTouch: A Prefilled Insulin Pen with a Novel Injection Mechanism with Consistent High Accuracy at Low- (1 U), Medium- (40 U), and High- (80 U) Dose Settings. Journal of Diabetes Science and Technology. 5(5). 1195–1199. 21 indexed citations

5.

Nexø, Ebba, et al.. (1989). Human intrinsic factor. Its primary structure compared to the primary structure of rat intrinsic factor.. PubMed. 194. 19–22. 2 indexed citations

6.

Daugaard, Gedske, Ulrik Abildgaard, Niels‐Henrik Holstein‐Rathlou, et al.. (1988). Renal tubular function in patients treated with high-dose cisplatin. Clinical Pharmacology & Therapeutics. 44(2). 164–172. 112 indexed citations

7.

Bucher, D., et al.. (1986). Cerebrospinal Fluid Glutamine in Intracranial Hemorrhage in the Newborn. Acta Paediatrica. 75(6). 899–904. 2 indexed citations

8.

ANDERSEN, G. E., et al.. (1983). Plasma Amino Acid Concentrations in Newborn Infants during Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition. 7(4). 369–373. 5 indexed citations

9.

Vilstrup, Hendrik, et al.. (1982). Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. European Journal of Clinical Investigation. 12(3). 197–202. 35 indexed citations

10.

Prahl, P., D. Bucher, Torben Plesner, B. Weeke, & H. Løwenstein. (1982). Isolation and Partial Characterisation of Three Major Allergens in an Extract from Cow Hair and Dander. International Archives of Allergy and Immunology. 67(4). 293–301. 23 indexed citations

11.

Nexø, Ebba, et al.. (1978). Primary structure of human intrinsic factor: progress report on cyanogen bromide fragmentation. Scandinavian Journal of Clinical and Laboratory Investigation. 38(7). 649–653. 7 indexed citations

12.

Bucher, D.. (1977). Identification of subnanomole amounts of PTH-amino acids by high performance thin-layer chromatography. Chromatographia. 10(12). 723–725. 11 indexed citations

13.

Nexø, Ebba, H. Olesen, D. Bucher, & Johannes Thomsen. (1977). Purification and characterization of rabbit transcobalamin II. Biochimica et Biophysica Acta (BBA) - Protein Structure. 494(2). 395–402. 25 indexed citations

14.

Bucher, D., et al.. (1976). Identification of γ‐carboxyglutamic acid residues in bovine factors IX and X, and in a new vitamin K‐dependent protein. FEBS Letters. 68(2). 293–296. 48 indexed citations

15.

Olesen, H., Ebba Nexø, Per Lous, Johannes Thomsen, & D. Bucher. (1976). Amino Terminal Sequence of Human Intrinsic Factor. Scandinavian Journal of Clinical and Laboratory Investigation. 36(6). 527–529. 2 indexed citations

16.

Olesen, H., Ebba Nexø, Per Lous, Johannes Thomsen, & D. Bucher. (1976). Amino Terminal Sequence of Human Intrinsic Factor. Scandinavian Journal of Clinical and Laboratory Investigation. 36(6). 527–529. 2 indexed citations

17.

Thomsen, Johannes, D. Bucher, K. Brunfeldt, Ebba Nexø, & Henrik Olesen. (1976). An Improved Procedure for Automated Edman Degradation Used for Determination of the N‐Terminal Amino Acid Sequence of Human Transcobalamin I and Human Intrinsic Factor. European Journal of Biochemistry. 69(1). 87–96. 37 indexed citations

18.

Schou, Ole, et al.. (1976). N-Alkylation of Proline Residues by Chloromethyl Groups on the Resin in Solid-Phase Peptide Synthesis. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 357(1). 103–106. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact